After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $180.0 for Insmed, spanning the last three months.

Mycobacterium avium subspecies paratuberculosis (MAP) is a pathogenic bacterium responsible for Johne’s disease, a chronic granulomatous enteritis primarily affecting ruminants. This disease poses ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Accurate detection is essential to prevent misdiagnosis and ensure the right treatment, particularly in cases involving drug-resistant TB or NTM infections. The Hi-PCR ® MTB/NTM Probe PCR Kit offers a ...